This post was originally published on this site
Investing.com — McKesson rose 6% after raising its outlook and reporting better-than-expected results Monday..
McKesson Corporation (NYSE:MCK), which provides medical supplies and distributes pharmaceuticals, gave fiscal 2021 adjusted earnings per diluted share guidance in a range of $14.70 to $15.50, from the previous range of $13.95 to $14.75.
First quarter revenue of $55.7 billion came in flat from the previous year. Earnings per share of $2.77 beat the consensus of $2.32 a share.
The stock has eight buy ratings, four holds and no sells, with an average price target of $171.42, according to data compiled by Investing.com.
